ISRG's Aroon Indicator triggered a bullish signal on October 23, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 264 similar instances where the Aroon Indicator showed a similar pattern. In 178 of the 264 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 67%.
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on ISRG as a result. In 53 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
Following a +5.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where ISRG advanced for three days, in 210 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The 10-day RSI Indicator for ISRG moved out of overbought territory on October 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 12 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 32%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ISRG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
ISRG broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. ISRG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 51 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 73 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ISRG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.726) is normal, around the industry mean (5.000). P/E Ratio (50.765) is within average values for comparable stocks, (37.535). Projected Growth (PEG Ratio) (1.931) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (12.469) is also within normal values, averaging (56.876).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
MMSI moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 27 of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 68%.
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on MMSI as a result. In 54 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.
The Moving Average Convergence Divergence (MACD) for MMSI just turned positive on October 12, 2026. Looking at past instances where MMSI's MACD turned positive, the stock continued to rise in 22 of 36 cases over the following month. The odds of a continued upward trend are 61%.
The 10-day moving average for MMSI crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
Following a +3.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where MMSI advanced for three days, in 198 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The 10-day RSI Indicator for MMSI moved out of overbought territory on October 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 19 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MMSI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
MMSI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. MMSI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 52 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 72 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MMSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 74 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.320) is normal, around the industry mean (5.000). P/E Ratio (38.118) is within average values for comparable stocks, (37.535). Projected Growth (PEG Ratio) (1.574) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.273) is also within normal values, averaging (56.876).
ISRG | MMSI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 81 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 79 Overvalued | 75 Overvalued | |
PROFIT vs RISK RATING 1..100 | 73 | 72 | |
SMR RATING 1..100 | 51 | 74 | |
PRICE GROWTH RATING 1..100 | 45 | 40 | |
P/E GROWTH RATING 1..100 | 78 | 52 | |
SEASONALITY SCORE 1..100 | 85 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MMSI's Valuation (75) in the Medical Specialties industry is in the same range as ISRG (79). This means that MMSI’s stock grew similarly to ISRG’s over the last 12 months.
MMSI's Profit vs Risk Rating (72) in the Medical Specialties industry is in the same range as ISRG (73). This means that MMSI’s stock grew similarly to ISRG’s over the last 12 months.
ISRG's SMR Rating (51) in the Medical Specialties industry is in the same range as MMSI (74). This means that ISRG’s stock grew similarly to MMSI’s over the last 12 months.
MMSI's Price Growth Rating (40) in the Medical Specialties industry is in the same range as ISRG (45). This means that MMSI’s stock grew similarly to ISRG’s over the last 12 months.
MMSI's P/E Growth Rating (52) in the Medical Specialties industry is in the same range as ISRG (78). This means that MMSI’s stock grew similarly to ISRG’s over the last 12 months.
| ISRG | MMSI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 32% | 1 day ago 50% |
| Stochastic ODDS (%) | 1 day ago 61% | 1 day ago 52% |
| Momentum ODDS (%) | 1 day ago 67% | 1 day ago 58% |
| MACD ODDS (%) | N/A | 1 day ago 61% |
| TrendWeek ODDS (%) | 1 day ago 65% | 1 day ago 57% |
| TrendMonth ODDS (%) | 1 day ago 66% | 1 day ago 58% |
| Advances ODDS (%) | 8 days ago 66% | 9 days ago 66% |
| Declines ODDS (%) | 3 days ago 61% | 3 days ago 56% |
| BollingerBands ODDS (%) | 1 day ago 42% | 1 day ago 51% |
| Aroon ODDS (%) | 1 day ago 67% | N/A |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ISRG’s FA Score shows that 0 FA rating(s) are green while MMSI’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ISRG’s TA Score shows that 3 TA indicator(s) are bullish while MMSI’s TA Score has 5 bullish TA indicator(s).
ISRG (@Pharmaceuticals: Other) experienced а +1.11% price change this week, while MMSI (@Pharmaceuticals: Other) price change was -0.59% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.22%. For the same industry, the average monthly price growth was -1.95%, and the average quarterly price growth was +11.27%.
ISRG is expected to report earnings on Jan 26, 2027.
MMSI is expected to report earnings on Feb 24, 2027.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
A.I.dvisor indicates that over the last year, MMSI has been loosely correlated with BSX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MMSI jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To MMSI | 1D Price Change % | ||
|---|---|---|---|---|
| MMSI | 100% | +1.28% | ||
| BSX - MMSI | 56% Loosely correlated | +0.61% | ||
| SYK - MMSI | 50% Loosely correlated | +2.55% | ||
| ICUI - MMSI | 50% Loosely correlated | +1.36% | ||
| BDX - MMSI | 44% Loosely correlated | +1.63% | ||
| ISRG - MMSI | 43% Loosely correlated | +1.03% | ||
More | ||||